Revelation Biosciences (REVB) Other Non-Current Liabilities (2020 - 2025)
Revelation Biosciences (REVB) recorded Other Non-Current Liabilities of $175.00 in Q3 2025, down 96.4% from $4,803 a year earlier and down 77.7% from the prior quarter.
Powered by 
Analysis
Revelation Biosciences (REVB) Other Non-Current Liabilities (2020 - 2025) Analysis & Trends
At the end of FY2024, Revelation Biosciences reported Other Non-Current Liabilities of $2,246, down 98.4% from FY2023.
- Annual Other Non-Current Liabilities has a four-year compound annual growth rate of -80.3% (FY2020 to FY2024).
- Across earlier years, Other Non-Current Liabilities came in at $141,276 in FY2023, $1.01 million in FY2021 (-32.4%) and $1.49 million in FY2020.
- The Q3 2025 figure is the lowest quarterly Other Non-Current Liabilities in data going back to Q4 2020.
- On a year-over-year basis, Other Non-Current Liabilities has declined for seven consecutive quarters, with an average decline of 96.5% over the last seven quarters.
- The year-over-year decline in Other Non-Current Liabilities has ranged between 32.4% (Q4 2021) and 99.6% (Q1 2024) over the last five years.
- Per Business Quant, the preceding three quarters came in at $786.00 (Q2 2025), $829.00 (Q1 2025) and $2,246 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.76 Bn | 1,105.35 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 618.64 Bn | 537.17 Bn | 17.26 Bn |
| 3 | AbbVie | 502.02 Bn | 475.13 Bn | 12.70 Bn |
| 4 | Merck | 368.10 Bn | 322.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.96 Bn | 261.95 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.11 Bn | 234.80 Bn | 12.86 Bn |
| 7 | Amgen | 236.64 Bn | 192.04 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.15 Bn | 165.35 Bn | 6.22 Bn |
| 9 | Pfizer | 169.69 Bn | 116.33 Bn | 10.94 Bn |
| 10 | Revelation Biosciences | 14.17 Mn | -34.85 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 175.00 |
| Jun 30, 2025 | 786.00 |
| Mar 31, 2025 | 829.00 |
| Dec 31, 2024 | 2,246.00 |
| Sep 30, 2024 | 4,803.00 |
| Jun 30, 2024 | 10,844.00 |
| Mar 31, 2024 | 15,260.00 |
| Dec 31, 2023 | 141,276.00 |
| Sep 30, 2023 | 209,478.00 |
| Jun 30, 2023 | 302,039.00 |
| Mar 31, 2023 | 3.51 Mn |
| Dec 31, 2021 | 1.01 Mn |
| Dec 31, 2020 | 1.49 Mn |
API Access
Revelation Biosciences Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();